TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published23
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS Framework - Blood Disorders including Haemophilia A and B - July 2024". Published status: complete. Published value: Value not published. 23 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
66.2Bids / Report
11.9% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 515 active published awards; 512 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published11 Jun 2024, 14:27 BST
Last source update11 Jun 2024, 14:27 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-043b0e
What is being bought
Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024<br/><br/>Offer reference number: CM/PHS/22/5661<br/><br/>Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 14 months.<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
What changed
From the official release history
  1. Status changed to complete
    11 Jun 2024, 14:27 BST
  2. Official notice release published
    11 Jun 2024, 14:27 BST
  3. tender value changed
    24 May 2024, 09:06 BST
  4. Status changed to published status
    24 May 2024, 09:06 BST
  5. Official notice release published
    24 May 2024, 09:06 BST
  6. Submission deadline changed to published date
    24 May 2024, 09:06 BST
  7. Published value updated to £1,168,000,000
    19 Feb 2024, 11:12 GMT
  8. Status changed to active
    19 Feb 2024, 11:12 GMT
  9. Official notice release published
    19 Feb 2024, 11:12 GMT
  10. Submission deadline changed to 21 Mar 2024, 13:00 GMT
    19 Feb 2024, 11:12 GMT
  11. Buyer information updated
    19 Feb 2024, 11:12 GMT
Lots and requirements (23)
Published by the contracting authority
  • Lot 1 · #1
    CM/PHS/22/5661/01 Standard Half-life Recombinant Factor VIII
    cancelled
    Published valueNot published
    Standard Half-life Recombinant Factor VIII
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #10
    CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction
    cancelled
    Published valueNot published
    CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #11
    CM/PHS/22/5661/11 Factor IX - High Purity Factor IX
    cancelled
    Published valueNot published
    CM/PHS/22/5661/11 Factor IX - High Purity Factor IX
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #12
    CM/PHS/22/5661/12 Factor X
    cancelled
    Published valueNot published
    CM/PHS/22/5661/12 Factor X
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #13
    CM/PHS/22/5661/13 Factor XIII - Plasma Derived
    cancelled
    Published valueNot published
    CM/PHS/22/5661/13 Factor XIII - Plasma Derived
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 6 · #14
    CM/PHS/22/5661/14 Factor XIII - Recombinant
    cancelled
    Published valueNot published
    CM/PHS/22/5661/14 Factor XIII - Recombinant
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 7 · #15
    CM/PHS/22/5661/15 Von willebrands factor / Factor VIII
    cancelled
    Published valueNot published
    CM/PHS/22/5661/15 Von willebrands factor / Factor VIII
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 8 · #16
    CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived
    cancelled
    Published valueNot published
    CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 9 · #17
    CM/PHS/22/5661/17 Von willebrands factor - Recombinant
    cancelled
    Published valueNot published
    CM/PHS/22/5661/17 Von willebrands factor - Recombinant
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 10 · #18
    CM/PHS/22/5661/18 Fibrinogen Concentrate
    cancelled
    Published valueNot published
    CM/PHS/22/5661/18 Fibrinogen Concentrate
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 11 · #19
    CM/PHS/22/5661/19 Prothrombin Complex dried
    cancelled
    Published valueNot published
    CM/PHS/22/5661/19 Prothrombin Complex dried
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 12 · #2
    CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII
    cancelled
    Published valueNot published
    CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 13 · #20
    CM/PHS/22/5661/20 Protein C Concentrate
    cancelled
    Published valueNot published
    CM/PHS/22/5661/20 Protein C Concentrate
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 14 · #21
    CM/PHS/22/5661/21 Fresh Frozen Plasma (all blood groups)
    cancelled
    Published valueNot published
    CM/PHS/22/5561/21 Fresh Frozen Plasma (all blood groups)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 15 · #22
    CM/PHS/22/5661/22 Freeze Dried Plasma
    cancelled
    Published valueNot published
    CM/PHS/22/5661/22 Freeze Dried Plasma
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 16 · #23
    CM/PHS/22/5661/23 Caplacizumab
    cancelled
    Published valueNot published
    CM/PHS/22/5661/23 Caplacizumab
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 17 · #3
    CM/PHS/22/5661/03 Emicizumab
    cancelled
    Published valueNot published
    CM/PHS/22/5661/03 Emicizumab
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 18 · #4
    CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL)
    cancelled
    Published valueNot published
    CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 19 · #5
    CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL)
    cancelled
    Published valueNot published
    CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 20 · #6
    CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL)
    cancelled
    Published valueNot published
    CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL)
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 21 · #7
    CM/PHS/22/5661/07 rFIX - Standard Half Life
    cancelled
    Published valueNot published
    CM/PHS/22/5661/07 rFIX - Standard Half Life
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 22 · #8
    CM/PHS/22/5661/08 Recombinant Factor VII
    cancelled
    Published valueNot published
    CM/PHS/22/5661/08 Recombinant Factor VII
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 23 · #9
    CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa
    cancelled
    Published valueNot published
    CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    11 Jun 2024, 14:27 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Award active
    Not published · Not published
  21. Award active
    Not published · Not published
  22. Award active
    Not published · Not published
  23. Award active
    Not published · Not published
  24. Award active
    Not published · Not published
  25. Award active
    Not published · Not published
  26. Award active
    Not published · Not published
  27. Award unsuccessful
    Not published · Not published
  28. Award unsuccessful
    Not published · Not published
  29. Award active
    Not published · Not published
  30. Award active
    Not published · Not published
  31. Award active
    Not published · Not published
  32. Award active
    Not published · Not published
  33. Award active
    Not published · Not published
  34. Award active
    Not published · Not published
  35. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  36. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  37. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  38. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  39. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  40. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  41. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  42. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  43. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  44. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  45. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  46. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  47. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  48. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  49. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  50. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  51. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  52. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  53. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  54. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  55. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  56. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  57. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  58. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  59. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  60. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  61. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  62. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  63. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  64. Contract active
    Signed 31 May 2024, 00:00 BST · £1
  65. Contract active
    Signed 31 May 2024, 00:00 BST · £1
Commercial outcome and competition
Awards
Pfizer Ltd
Not published · Not published · active
Pfizer Ltd
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
Novo Nordisk
Not published · Not published · active
LFB
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
Bio Products Laboratory Ltd
Not published · Not published · active
Bio Products Laboratory Ltd
Not published · Not published · active
CSL Behring UK Ltd
Not published · Not published · active
Novo Nordisk
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
Octapharma Limited
Not published · Not published · active
CSL Behring UK Ltd
Not published · Not published · active
LFB
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
LFB
Not published · Not published · active
Octapharma Limited
Not published · Not published · active
CSL Behring UK Ltd
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
Octapharma Limited
Not published · Not published · active
CSL Behring UK Ltd
Not published · Not published · active
Octapharma Limited
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
Octapharma Limited
Not published · Not published · active
Freeze Dried Plasma
Not published · Not published · unsuccessful
Caplacizumab
Not published · Not published · unsuccessful
Novo Nordisk
Not published · Not published · active
Sobi (Swedish Orphan Biovitrum Ltd)
Not published · Not published · active
Roche Products Ltd
Not published · Not published · active
Sobi (Swedish Orphan Biovitrum Ltd)
Not published · Not published · active
CSL Behring UK Ltd
Not published · Not published · active
Novo Nordisk
Not published · Not published · active
Contracts
Standard Half-life Recombinant Factor VIII
£1 · signed 31 May 2024, 00:00 BST · active
rFIX - Standard Half Life
£1 · signed 31 May 2024, 00:00 BST · active
rFIX - Standard Half Life
£1 · signed 31 May 2024, 00:00 BST · active
Recombinant Factor VII
£1 · signed 31 May 2024, 00:00 BST · active
Recombinant Factor VII
£1 · signed 31 May 2024, 00:00 BST · active
Porcine Factor VIII - susoctocog alfa
£1 · signed 31 May 2024, 00:00 BST · active
Factor VIII Inhibitor Bypassing Fraction
£1 · signed 31 May 2024, 00:00 BST · active
Factor IX - High Purity Factor IX
£1 · signed 31 May 2024, 00:00 BST · active
Factor X
£1 · signed 31 May 2024, 00:00 BST · active
Factor XIII - Plasma Derived
£1 · signed 31 May 2024, 00:00 BST · active
Factor XIII - Recombinant
£1 · signed 31 May 2024, 00:00 BST · active
Standard Half-life Recombinant Factor VIII
£1 · signed 31 May 2024, 00:00 BST · active
Von willebrands factor / Factor VIII
£1 · signed 31 May 2024, 00:00 BST · active
Von willebrands factor / Factor VIII
£1 · signed 31 May 2024, 00:00 BST · active
Von willebrands factor - Plasma Derived
£1 · signed 31 May 2024, 00:00 BST · active
Von willebrands factor - Recombinant
£1 · signed 31 May 2024, 00:00 BST · active
Fibrinogen Concentrate
£1 · signed 31 May 2024, 00:00 BST · active
Fibrinogen Concentrate
£1 · signed 31 May 2024, 00:00 BST · active
Fibrinogen Concentrate
£1 · signed 31 May 2024, 00:00 BST · active
Prothrombin Complex dried
£1 · signed 31 May 2024, 00:00 BST · active
Prothrombin Complex dried
£1 · signed 31 May 2024, 00:00 BST · active
Prothrombin Complex dried
£1 · signed 31 May 2024, 00:00 BST · active
Standard Half-life Recombinant Factor VIII
£1 · signed 31 May 2024, 00:00 BST · active
Protein C Concentrate
£1 · signed 31 May 2024, 00:00 BST · active
Fresh Frozen Plasma (all blood groups)
£1 · signed 31 May 2024, 00:00 BST · active
Enhanced Half-life Recombinant Factor VIII
£1 · signed 31 May 2024, 00:00 BST · active
Enhanced Half-life Recombinant Factor VIII
£1 · signed 31 May 2024, 00:00 BST · active
Emicizumab
£1 · signed 31 May 2024, 00:00 BST · active
Eftrenonacog alfa (rFIX EHL)
£1 · signed 31 May 2024, 00:00 BST · active
albutrepenonacog alfa (rFIX EHL)
£1 · signed 31 May 2024, 00:00 BST · active
nonacog beta pegol (rFIX EHL)
£1 · signed 31 May 2024, 00:00 BST · active
Bid statistics
bids: 3 (lot 1)
bids: 3 (lot 1)
bids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
electronicBids: 3 (lot 1)
foreignBidsFromEU: 3 (lot 1)
foreignBidsFromEU: 3 (lot 1)
foreignBidsFromEU: 3 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
smeBids: 0 (lot 1)
smeBids: 0 (lot 1)
smeBids: 0 (lot 1)
bids: 1 (lot 10)
electronicBids: 1 (lot 10)
foreignBidsFromEU: 1 (lot 10)
foreignBidsFromNonEU: 0 (lot 10)
smeBids: 0 (lot 10)
bids: 1 (lot 11)
electronicBids: 1 (lot 11)
foreignBidsFromEU: 1 (lot 11)
foreignBidsFromNonEU: 0 (lot 11)
smeBids: 0 (lot 11)
bids: 1 (lot 12)
electronicBids: 1 (lot 12)
foreignBidsFromEU: 1 (lot 12)
foreignBidsFromNonEU: 0 (lot 12)
smeBids: 0 (lot 12)
bids: 1 (lot 13)
electronicBids: 1 (lot 13)
foreignBidsFromEU: 1 (lot 13)
foreignBidsFromNonEU: 0 (lot 13)
smeBids: 0 (lot 13)
bids: 1 (lot 14)
electronicBids: 1 (lot 14)
foreignBidsFromEU: 1 (lot 14)
foreignBidsFromNonEU: 0 (lot 14)
smeBids: 0 (lot 14)
bids: 2 (lot 15)
bids: 2 (lot 15)
electronicBids: 2 (lot 15)
electronicBids: 2 (lot 15)
foreignBidsFromEU: 2 (lot 15)
foreignBidsFromEU: 2 (lot 15)
foreignBidsFromNonEU: 0 (lot 15)
foreignBidsFromNonEU: 0 (lot 15)
smeBids: 0 (lot 15)
smeBids: 0 (lot 15)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-67205
View buyer profile

  • NHS England
    buyer
    centralPurchasingBody

    1st Floor, Quarry House, Quarry Hill, Leeds, UKE, LS2 7UE
    katie.noonan@nhs.net

  • Bio Products Laboratory Ltd
    supplier

    07343036
    Dagger Lane,, Elstree, Hertfordshire, UK, WD6 3BX

  • CSL Behring UK Ltd
    supplier

    01622483
    4 Milton Road Haywards Heath, West Sussex, UK, RH16 1AH

  • LFB
    supplier

    01118740
    LFB Biopharmaceuticals Limited, Suite 104, Spirella Building, Bridge Road, Letchworth Garden City,, Hertfordshire,, UK, SG6 4ET.

  • Novo Nordisk
    supplier

    02372699
    3 City Place. Beehive Ring Road., Gatwick. West Sussex, UK, RH6 0PA

  • Octapharma Limited
    supplier

    526209
    Glassworks House, 32 Shudehill,, Manchester,, UK, M4 1EZ

  • Pfizer Ltd
    supplier

    100674
    Walton Oaks, Dorking Road, Walton-on-the-Hill, Tadworth,, Surrey,, UK, KT20 7NS

  • Roche Products Ltd
    supplier

    04369760
    Hexagon Place, Falcon Way, Shire Park,, Welwyn Garden City, UK, AL7 1TW

  • Sobi (Swedish Orphan Biovitrum Ltd)
    supplier

    03362860
    Swedish Orphan Biovitrum Ltd, Suite 2, Riverside 3, Great Abington,, Cambridgeshire., UK, CB21 6AD

  • Takeda UK Ltd
    supplier

    03362860
    1 Kingdom Street,, London, UK, W2 6BD

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published